Phenindamine


Concise Prescribing Info
Indications/Uses
Allergic conditions.
Dosage/Direction for Use
Adult : PO 25 mg 4-6 hrly. Max: 150 mg/24 hr.
Dosage Details
Oral
Allergic conditions
Adult: As tartrate: 25 mg every 4-6 hr. Max: 150 mg in 24 hr.
Child: As tartrate: ≥6 yr: 12.5 mg every 4-6 hr. Max: 75 mg in 24 hr.
Special Precautions
Narrow-angle glaucoma, GI ulcer, urinary retention (enlarged prostate), heart disease, hypertension, convulsions, respiratory disease, hyperthyroidism. May impair ability to drive or operate machinery. Pregnancy and lactation.
Adverse Reactions
Drowsiness, dizziness, headache, loss of appetite, stomach upset, visual disturbances, irritability, dry mouth. CNS stimulation may occur in certain individuals.
Overdosage
Symptoms: In children: Abnormal eye movements, facial flushing, dry mouth, fever, excitation, agitation, bizarre behaviour, confusion, restlessness, irritability, delirium, twitching, tiredness, trembling, slurred speech, seizures, abnormal tongue movement. In adults: Drowsiness, unconsciousness, excitement, seizures.
Drug Interactions
Additive CNS depression with alcohol, barbiturates, hypnotics, opioid analgesics, anxiolytic sedatives and neuroleptics, other CNS depressants.
Lab Interference
May interfere with skin allergy testing.
Action
Description: Phenindamine is a sedating antihistamine derived from piperidine.
Duration: 4-6 hr.
Storage
Store at 15-30°C (59-86°F) away from moisture and light.
Disclaimer: This information is independently developed by MIMS based on Phenindamine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in